Hemianopia, Homonymous, Hemianopsia, Homonymous
Conditions
Keywords
Hemianopia, Virtual Reality, Rehabilitation, Hemianopsia
Brief summary
The purpose of this research study is to investigate the effectiveness of a new rehabilitation for visual hemianopia. The study team believes a cross-modal rehabilitation technique delivered by a virtual reality system can help restore the visual field for subjects with homonymous hemianopia.
Detailed description
The study tests a novel rehabilitation system, translated from promising cross-modal rehabilitation animal research, that is the first treatment capable of restoring the visual field for hemianopia patients. This noninvasive technique uses a virtual reality device to deliver visual and auditory stimulus. The goals of this study are to obtain proof of concept and procure rehabilitation data to support the development of this novel rehabilitation treatment.
Interventions
Subjects will put on a virtual reality rehabilitation system which will present sights and sounds.
Sponsors
Study design
Intervention model description
All study participants will be given the same treatment.
Eligibility
Inclusion criteria
* Adult volunteers diagnosed with homonymous visual hemianopia / hemianopsia (ages 18-99)
Exclusion criteria
* Volunteers who are unable to complete the study tasks or understand instructions * Subjects that are not able to provide written consent or verbal assent * Subjects who are not available to complete all rehabilitation sessions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Humphrey Visual Field Perimetry | Baseline | The area of the subject's visual field measured by 30-2 Humphrey visual field (HVF) perimetry. Both left and right sides will be tested. The deficit side includes is the hemianopic side. The intact side is the non-hemianopic side. During the HVF test, light is projected into a white bowl with a standardized background light intensity to form a circular stimulus, around 30 cm away from the patient's eye. The overall field mapping technique used is a form of static perimetry, where a stimulus appears in various areas of the field of vision. The patient indicates when they can see the stimulus and the perimetrist then records the point where the stimulus was seen. These data points are used to determine the patient's visual field. |
| Virtual Reality (VR) Visual Field Test--Mean Percent Correct | Day 1 | Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals. |
| Virtual Reality Visual Field Test--Mean Percent Correct | Day 2 | Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals. |
| Peripheral Visual Field Frame Test | Baseline | The number of points subjects can detect in each location of the visual field along the horizontal meridian. Percent of correct trials in each location tested in the deficit and intact side. Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| VA LV VFQ-48--Reading Domain Score | Baseline, 2 months | The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The reading domain score is calculated by calculating the average score of reading items. Scores range from 0 to 3.5 logits, with higher scores denoting better ability to perform activities. The Reading Domain Score is the average functional reserve of the items measuring the reading functional domain, excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons). |
| Veterans Affairs Low Vision Visual Function Questionnaire-48 (VA LV VFQ-48)--Item Score | Baseline, 2 months | The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 (most difficult) and \>=-2.22 (least difficult). Scores out of this range indicate something other than visual impairment is governing the patient's responses. The Item Score is the average functional reserve of all the items in the questionnaire excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons). Functional reserve is the difference between a patient's visual ability and the visual ability needed to perform an activity. |
| VA LV VFQ-48--Item Score | 3 months | The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 (most difficult) and \>=-2.22 (least difficult). Scores out of this range indicate something other than visual impairment is governing the patient's responses. The Item Score is the average functional reserve of all the items in the questionnaire excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons). Functional reserve is the difference between a patient's visual ability and the visual ability needed to perform an activity. |
| VA LV VFQ-48--Composite Score | Baseline, 2 months | The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 and \>=-2.22. Scores out of this range indicate something other than visual impairment is governing the patient's responses. The reading domain score is calculated by calculating the average score of reading items. The composite score approximates a person's visual ability. The score is calculated using Massof's algorithm using the inverse hyperbolic tangent equation. For the composite score, a lower score is better. |
| National Eye Institute Visual Function Questionnaire (NEI-VFQ-25)--Composite Score | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. This score is calculated from the average of all subscale scores in the NEI VFQ-25 excluding the general health score. The score ranges from 0 to 100. A higher score denotes better vision-related quality of life. |
| NEI-VFQ-25--Composite Score | 6 month | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. This score is calculated from the average of all subscale scores in the NEI VFQ-25 excluding the general health score. The score ranges from 0 to 100. A higher score denotes better vision-related quality of life. |
| NEI-VFQ-25--General Health Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The General Health Score is a subscale that measures the participant's self-report of their overall health. The score ranges from 0 to 100. A higher score denotes better perception of overall health. |
| NEI-VFQ-25--General Vision Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The General Vision Score measures the participant's reported quality of vision. The score ranges from 0 to 100. A higher score denotes a better perception of vision |
| NEI-VFQ-25--Ocular Pain Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Ocular Pain Score Subscale measures reported pain or discomfort in and around the eyes. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to ocular pain. |
| NEI-VFQ-25--Near Activities Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Near Activities Score Subscale measures difficulty with performing near activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to near activities. |
| NEI-VFQ-25--Distance Activities Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Distance Activities Score Subscale measures difficulty with performing distance activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to distance activities. |
| NEI-VFQ-25--Social Functioning Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Social Functioning Score Subscale measures how vision difficulties affect social functioning. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to social functioning. |
| NEI-VFQ-25--Mental Health Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Mental Health Score Subscale measures how much patients feel vision affects their mental health. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life relating to mental health. |
| NEI-VFQ-25--Role Difficulties Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Role Difficulties Score Subscale measures how limited by their vision patients feel they are. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life relating to role difficulties. |
| NEI-VFQ-25--Dependency Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Dependency Score Subscale measures how much patients are dependent on other people due to their vision. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to dependency. |
| NEI-VFQ-25--Driving Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Driving Score Subscale measures patients' reported difficulty with driving. The score ranges from 0 to 100. Patients who do not drive are not given a driving score. A higher score denotes better vision-specific quality of life related to driving. |
| NEI-VFQ-25--Color Vision Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Color Vision Score Subscale measures how much difficulty patients have with using color vision to complete daily activities such as picking out clothes. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to color vision. |
| NEI-VFQ-25--Peripheral Vision Score Subscale | Baseline, 2 months, 3 months | The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Peripheral Vision Score Subscale measures how much difficulty patients have with their peripheral vision to complete daily activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to peripheral vision. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Color Vision Test | First visit after the completion of rehabilitation (1 or 2 months) | Change in the percentage of correctly identified trials for each color. |
| Shape Recognition Test | First visit after the completion of rehabilitation (1 or 2 months) | Change in the percentage of correctly identified trials. |
| Grating Acuity Test | First visit after the completion of rehabilitation (1 or 2 months) | Change in the percentage of correctly identified trials. |
Countries
United States
Participant flow
Recruitment details
Six subjects signed consent. One screen failed.
Participants by arm
| Arm | Count |
|---|---|
| Experimental Group Virtual Reality (VR) Treatment Visual Auditory Virtual Reality rehabilitation for visual hemianopia
Cross-model Visual Auditory Rehabilitation: Subjects will put on a virtual reality rehabilitation system which will present sights and sounds. | 5 |
| Total | 5 |
Withdrawals & dropouts
| Period | Reason | FG000 |
|---|---|---|
| Overall Study | Screen Failure | 1 |
Baseline characteristics
| Characteristic | Experimental Group Virtual Reality (VR) Treatment |
|---|---|
| Age, Continuous | 62.6 years STANDARD_DEVIATION 13.667 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 5 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants |
| Race (NIH/OMB) White | 5 Participants |
| Region of Enrollment United States | 5 participants |
| Sex: Female, Male Female | 4 Participants |
| Sex: Female, Male Male | 1 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 6 |
| other Total, other adverse events | 0 / 6 |
| serious Total, serious adverse events | 0 / 6 |
Outcome results
Humphrey Visual Field Perimetry
The area of the subject's visual field measured by 30-2 Humphrey visual field (HVF) perimetry. Both left and right sides will be tested. The deficit side includes is the hemianopic side. The intact side is the non-hemianopic side. During the HVF test, light is projected into a white bowl with a standardized background light intensity to form a circular stimulus, around 30 cm away from the patient's eye. The overall field mapping technique used is a form of static perimetry, where a stimulus appears in various areas of the field of vision. The patient indicates when they can see the stimulus and the perimetrist then records the point where the stimulus was seen. These data points are used to determine the patient's visual field.
Time frame: Baseline
Population: Analysis only includes subjects who completed study.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Humphrey Visual Field Perimetry | 108 visual angle degrees^2 | Standard Deviation 198.49 |
| Virtual Reality (VR) Treatment-Intact | Humphrey Visual Field Perimetry | 1272 visual angle degrees^2 | Standard Deviation 117.58 |
Humphrey Visual Field Perimetry
The area of the subject's visual field measured by 30-2 Humphrey visual field (HVF) perimetry. Both left and right sides will be tested. The deficit side includes is the hemianopic side. The intact side is the non-hemianopic side. During the HVF test, light is projected into a white bowl with a standardized background light intensity to form a circular stimulus, around 30 cm away from the patient's eye. The overall field mapping technique used is a form of static perimetry, where a stimulus appears in various areas of the field of vision. The patient indicates when they can see the stimulus and the perimetrist then records the point where the stimulus was seen. These data points are used to determine the patient's visual field.
Time frame: up to 2 Months
Population: Analysis only includes subjects who completed study.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Humphrey Visual Field Perimetry | 594 visual angle degrees^2 | Standard Deviation 542.99 |
| Virtual Reality (VR) Treatment-Intact | Humphrey Visual Field Perimetry | 1356 visual angle degrees^2 | Standard Deviation 18.59 |
Peripheral Visual Field Frame Test
The number of points subjects can detect in each location of the visual field along the horizontal meridian. Percent of correct trials in each location tested in the deficit and intact side. Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested.
Time frame: 6 Months
Population: Due to study timeline constraints, only one subject completed the 6 month follow-up test.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 15 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 60 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 30 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 75 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 45 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 75 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 45 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 15 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 30 Degrees | 100 Percent of correct trials |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 60 Degrees | 100 Percent of correct trials |
Peripheral Visual Field Frame Test
The number of points subjects can detect in each location of the visual field along the horizontal meridian. Percent of correct trials in each location tested in the deficit and intact side. Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested.
Time frame: Baseline
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 15 Degrees | 20 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 60 Degrees | 20 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 45 Degrees | 20 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 75 Degrees | 0 Percent of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 30 Degrees | 20 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 75 Degrees | 76 Percent of correct trials | Standard Deviation 43.359 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 15 Degrees | 80 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 30 Degrees | 80 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 45 Degrees | 80 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 60 Degrees | 72 Percent of correct trials | Standard Deviation 43.8178 |
Peripheral Visual Field Frame Test
The number of points subjects can detect in each location of the visual field along the horizontal meridian. Percent of correct trials in each location tested in the deficit and intact side. Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested.
Time frame: up to 2 Months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 60 Degrees | 80 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 45 Degrees | 92 Percent of correct trials | Standard Deviation 17.8885 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 30 Degrees | 96 Percent of correct trials | Standard Deviation 8.9443 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 75 Degrees | 60 Percent of correct trials | Standard Deviation 54.7723 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 15 Degrees | 100 Percent of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 75 Degrees | 92 Percent of correct trials | Standard Deviation 17.8885 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 15 Degrees | 80 Percent of correct trials | Standard Deviation 44.7214 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 60 Degrees | 100 Percent of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 30 Degrees | 96 Percent of correct trials | Standard Deviation 8.9443 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 45 Degrees | 100 Percent of correct trials | Standard Deviation 0 |
Peripheral Visual Field Frame Test
The number of points subjects can detect in each location of the visual field along the horizontal meridian. Percent of correct trials in each location tested in the deficit and intact side. Locations at 15°, 30°, 45°, 60°, and 75° on the horizontal meridian on the left and right side were tested.
Time frame: 3 Months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 30 Degrees | 90 Percent of correct trials | Standard Deviation 20 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 60 Degrees | 75 Percent of correct trials | Standard Deviation 50 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 45 Degrees | 80 Percent of correct trials | Standard Deviation 40 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 75 Degrees | 65 Percent of correct trials | Standard Deviation 47.2582 |
| Virtual Reality (VR) Treatment--Deficit Eye | Peripheral Visual Field Frame Test | 15 Degrees | 95 Percent of correct trials | Standard Deviation 10 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 75 Degrees | 100 Percent of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 15 Degrees | 90 Percent of correct trials | Standard Deviation 20 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 30 Degrees | 90 Percent of correct trials | Standard Deviation 20 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 45 Degrees | 100 Percent of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Peripheral Visual Field Frame Test | 60 Degrees | 100 Percent of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 4
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 6
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 7
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 58.333 percentage of correct trials | Standard Deviation 35.355 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 8
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19. One subject did not complete the test day 8, so no data was collected for any subjects for this day.
| Arm | Measure | Group | Value |
|---|---|---|---|
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | — |
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | — |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 9
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 10
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 11
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19. One subject did not complete the test day 11, so no data was collected for any subjects for this day.
| Arm | Measure | Group | Value |
|---|---|---|---|
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | — |
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | — |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 12
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.33 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 91.667 percentage of correct trials | Standard Deviation 11.785 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 13
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 41.667 percentage of correct trials | Standard Deviation 58.926 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 14
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 58.333 percentage of correct trials | Standard Deviation 58.926 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 15
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 91.667 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 16
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 17
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 18
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 19
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 91.667 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 20
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 21
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19. One subject did not complete the test day 21, so no data was collected for any subjects for this day.
| Arm | Measure | Group | Value |
|---|---|---|---|
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | — |
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | — |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 22
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 47.14 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 41.667 percentage of correct trials | Standard Deviation 58.926 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 91.667 percentage of correct trials | Standard Deviation 11.785 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 23
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19. One subject did not complete the test day 23, so no data was collected for any subjects for this day.
| Arm | Measure | Group | Value |
|---|---|---|---|
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | — |
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | — |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 24
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19. One subject did not complete the test day 24, so no data was collected for any subjects for this day.
| Arm | Measure | Group | Value |
|---|---|---|---|
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | — |
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | — |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 25
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 58.333 percentage of correct trials | Standard Deviation 58.926 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 66.667 percentage of correct trials | Standard Deviation 47.14 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 26
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 27
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19. One subject did not complete the test day 27, so no data was collected for any subjects for this day.
| Arm | Measure | Group | Value |
|---|---|---|---|
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | — |
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | — |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 28
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19. Data was not collected for 3 subjects due to logistical issues during COVID-19. One subject did not complete the test day 28, so no data was collected for any subjects for this day.
| Arm | Measure | Group | Value |
|---|---|---|---|
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | — |
| Unknown | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | — |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 29
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 66.667 percentage of correct trials | Standard Deviation 47.14 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 50 percentage of correct trials | Standard Deviation 70.711 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 5
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 2
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 16.667 percentage of correct trials | Standard Deviation 23.57 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 3
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 8.333 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 15 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
Virtual Reality (VR) Visual Field Test--Mean Percent Correct
Percent of correct trials in each location tested. Location at 15 degrees and 30 degrees on the horizontal meridian on both the left and right side were tested. Virtual Reality Visual Field test is a brief 5-minute test using the VR system to track rehabilitation progress. The test consists of 30 trials with visual stimulus presented either 15° or 30° in either the hemianopia field or the intact field at random time intervals.
Time frame: Day 1
Population: Data was not collected for 3 subjects due to logistical issues during COVID-19.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality (VR) Visual Field Test--Mean Percent Correct | 15 Degrees | 0 percentage of correct trials | Standard Deviation 0 |
| Virtual Reality (VR) Treatment--Deficit Eye | Virtual Reality (VR) Visual Field Test--Mean Percent Correct | 30 Degrees | 8.33 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality (VR) Visual Field Test--Mean Percent Correct | 15 Degrees | 91.667 percentage of correct trials | Standard Deviation 11.785 |
| Virtual Reality (VR) Treatment-Intact | Virtual Reality (VR) Visual Field Test--Mean Percent Correct | 30 Degrees | 100 percentage of correct trials | Standard Deviation 0 |
National Eye Institute Visual Function Questionnaire (NEI-VFQ-25)--Composite Score
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. This score is calculated from the average of all subscale scores in the NEI VFQ-25 excluding the general health score. The score ranges from 0 to 100. A higher score denotes better vision-related quality of life.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | National Eye Institute Visual Function Questionnaire (NEI-VFQ-25)--Composite Score | Baseline | 60.793 score on a scale | Standard Deviation 19.498 |
| Virtual Reality (VR) Treatment--Deficit Eye | National Eye Institute Visual Function Questionnaire (NEI-VFQ-25)--Composite Score | 2 months | 68.621 score on a scale | Standard Deviation 21.932 |
| Virtual Reality (VR) Treatment--Deficit Eye | National Eye Institute Visual Function Questionnaire (NEI-VFQ-25)--Composite Score | 3 months | 69.893 score on a scale | Standard Deviation 29.418 |
NEI-VFQ-25--Color Vision Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Color Vision Score Subscale measures how much difficulty patients have with using color vision to complete daily activities such as picking out clothes. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to color vision.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Color Vision Score Subscale | Baseline | 75 score on a scale | Standard Deviation 20.412 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Color Vision Score Subscale | 2 months | 87.5 score on a scale | Standard Deviation 14.434 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Color Vision Score Subscale | 3 months | 87.5 score on a scale | Standard Deviation 17.678 |
NEI-VFQ-25--Color Vision Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Color Vision Score Subscale measures how much difficulty patients have with using color vision to complete daily activities such as picking out clothes. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to color vision.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Color Vision Score Subscale | 100 score on a scale |
NEI-VFQ-25--Composite Score
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. This score is calculated from the average of all subscale scores in the NEI VFQ-25 excluding the general health score. The score ranges from 0 to 100. A higher score denotes better vision-related quality of life.
Time frame: 6 month
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Composite Score | 85.87 score on a scale |
NEI-VFQ-25--Dependency Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Dependency Score Subscale measures how much patients are dependent on other people due to their vision. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to dependency.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Dependency Score Subscale | Baseline | 41.667 score on a scale | Standard Deviation 35.355 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Dependency Score Subscale | 2 months | 50 score on a scale | Standard Deviation 41.388 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Dependency Score Subscale | 3 months | 62.5 score on a scale | Standard Deviation 53.033 |
NEI-VFQ-25--Dependency Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Dependency Score Subscale measures how much patients are dependent on other people due to their vision. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to dependency.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Dependency Score Subscale | 100 score on a scale |
NEI-VFQ-25--Distance Activities Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Distance Activities Score Subscale measures difficulty with performing distance activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to distance activities.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Distance Activities Score Subscale | Baseline | 48.333 score on a scale | Standard Deviation 18.609 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Distance Activities Score Subscale | 2 months | 76.25 score on a scale | Standard Deviation 19.167 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Distance Activities Score Subscale | 3 months | 77.5 score on a scale | Standard Deviation 20.035 |
NEI-VFQ-25--Distance Activities Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Distance Activities Score Subscale measures difficulty with performing distance activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to distance activities.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Distance Activities Score Subscale | 75 score on a scale |
NEI-VFQ-25--Driving Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Driving Score Subscale measures patients' reported difficulty with driving. The score ranges from 0 to 100. Patients who do not drive are not given a driving score. A higher score denotes better vision-specific quality of life related to driving.
Time frame: Baseline, 2 months, 3 months
Population: Driving Score Mean and Standard deviation could not be calculated because only one subject was driving and only for the 3 month follow up.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Driving Score Subscale | 3 months | 83.333 score on a scale |
| Unknown | NEI-VFQ-25--Driving Score Subscale | Baseline | — score on a scale |
| Unknown | NEI-VFQ-25--Driving Score Subscale | 2 months | — score on a scale |
NEI-VFQ-25--Driving Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Driving Score Subscale measures patients' reported difficulty with driving. The score ranges from 0 to 100. Patients who do not drive are not given a driving score. A higher score denotes better vision-specific quality of life related to driving.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Driving Score Subscale | 58.33 score on a scale |
NEI-VFQ-25--General Health Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The General Health Score is a subscale that measures the participant's self-report of their overall health. The score ranges from 0 to 100. A higher score denotes better perception of overall health.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--General Health Score Subscale | Baseline | 68.75 score on a scale | Standard Deviation 37.5 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--General Health Score Subscale | 2 months | 68.75 score on a scale | Standard Deviation 31.458 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--General Health Score Subscale | 3 months | 62.5 score on a scale | Standard Deviation 17.678 |
NEI-VFQ-25--General Health Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The General Health Score is a subscale that measures the participant's self-report of their overall health. The score ranges from 0 to 100. A higher score denotes better perception of overall health.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--General Health Score Subscale | 50 score on a scale |
NEI-VFQ-25--General Vision Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The General Vision Score measures the participant's reported quality of vision. The score ranges from 0 to 100. A higher score denotes a better perception of vision
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--General Vision Score Subscale | 80 score on a scale |
NEI-VFQ-25--General Vision Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The General Vision Score measures the participant's reported quality of vision. The score ranges from 0 to 100. A higher score denotes a better perception of vision
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--General Vision Score Subscale | Baseline | 65 score on a scale | Standard Deviation 19.149 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--General Vision Score Subscale | 2 months | 60 score on a scale | Standard Deviation 28.284 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--General Vision Score Subscale | 3 months | 70 score on a scale | Standard Deviation 14.142 |
NEI-VFQ-25--Mental Health Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Mental Health Score Subscale measures how much patients feel vision affects their mental health. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life relating to mental health.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Mental Health Score Subscale | 3 months | 56.25 score on a scale | Standard Deviation 61.872 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Mental Health Score Subscale | Baseline | 51.563 score on a scale | Standard Deviation 32.022 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Mental Health Score Subscale | 2 months | 48.4375 score on a scale | Standard Deviation 35.858 |
NEI-VFQ-25--Mental Health Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Mental Health Score Subscale measures how much patients feel vision affects their mental health. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life relating to mental health.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Mental Health Score Subscale | 98.73 score on a scale |
NEI-VFQ-25--Near Activities Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Near Activities Score Subscale measures difficulty with performing near activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to near activities.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Near Activities Score Subscale | 75 score on a scale |
NEI-VFQ-25--Near Activities Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Near Activities Score Subscale measures difficulty with performing near activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to near activities.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Near Activities Score Subscale | Baseline | 56.25 score on a scale | Standard Deviation 22.948 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Near Activities Score Subscale | 2 months | 60.417 score on a scale | Standard Deviation 31.458 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Near Activities Score Subscale | 3 months | 75 score on a scale | Standard Deviation 11.785 |
NEI-VFQ-25--Ocular Pain Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Ocular Pain Score Subscale measures reported pain or discomfort in and around the eyes. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to ocular pain.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Ocular Pain Score Subscale | Baseline | 90.625 score on a scale | Standard Deviation 6.25 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Ocular Pain Score Subscale | 2 months | 90.625 score on a scale | Standard Deviation 11.968 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Ocular Pain Score Subscale | 3 months | 81.25 score on a scale | Standard Deviation 26.517 |
NEI-VFQ-25--Ocular Pain Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Ocular Pain Score Subscale measures reported pain or discomfort in and around the eyes. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to ocular pain.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Ocular Pain Score Subscale | 100 score on a scale |
NEI-VFQ-25--Peripheral Vision Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Peripheral Vision Score Subscale measures how much difficulty patients have with their peripheral vision to complete daily activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to peripheral vision.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Peripheral Vision Score Subscale | Baseline | 50 score on a scale | Standard Deviation 35.3554 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Peripheral Vision Score Subscale | 2 months | 81.25 score on a scale | Standard Deviation 37.5 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Peripheral Vision Score Subscale | 3 months | 62.5 score on a scale | Standard Deviation 17.678 |
NEI-VFQ-25--Peripheral Vision Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Peripheral Vision Score Subscale measures how much difficulty patients have with their peripheral vision to complete daily activities. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to peripheral vision.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Peripheral Vision Score Subscale | 75 score on a scale |
NEI-VFQ-25--Role Difficulties Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Role Difficulties Score Subscale measures how limited by their vision patients feel they are. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life relating to role difficulties.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Role Difficulties Score Subscale | 100 score on a scale |
NEI-VFQ-25--Role Difficulties Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Role Difficulties Score Subscale measures how limited by their vision patients feel they are. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life relating to role difficulties.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Role Difficulties Score Subscale | Baseline | 62.5 score on a scale | Standard Deviation 32.275 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Role Difficulties Score Subscale | 2 months | 65.625 score on a scale | Standard Deviation 11.968 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Role Difficulties Score Subscale | 3 months | 50 score on a scale | Standard Deviation 70.711 |
NEI-VFQ-25--Social Functioning Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Social Functioning Score Subscale measures how vision difficulties affect social functioning. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to social functioning.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Social Functioning Score Subscale | 87.5 score on a scale |
NEI-VFQ-25--Social Functioning Score Subscale
The NEI-VFQ-25 is a 25-item questionnaire regarding the quality of vision, social functioning, visual dependency, near vision, and color vision. The Social Functioning Score Subscale measures how vision difficulties affect social functioning. The score ranges from 0 to 100. A higher score denotes better vision-specific quality of life related to social functioning.
Time frame: Baseline, 2 months, 3 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Social Functioning Score Subscale | Baseline | 55 score on a scale | Standard Deviation 24.495 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Social Functioning Score Subscale | 2 months | 70.625 score on a scale | Standard Deviation 35.259 |
| Virtual Reality (VR) Treatment--Deficit Eye | NEI-VFQ-25--Social Functioning Score Subscale | 3 months | 87.5 score on a scale | Standard Deviation 17.678 |
VA LV VFQ-48--Composite Score
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 and \>=-2.22. Scores out of this range indicate something other than visual impairment is governing the patient's responses. The reading domain score is calculated by calculating the average score of reading items. The composite score approximates a person's visual ability. The score is calculated using Massof's algorithm using the inverse hyperbolic tangent equation. For the composite score, a lower score is better.
Time frame: Baseline, 2 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Composite Score | Baseline | -1.607 Score on a Scale | Standard Deviation 1.923 |
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Composite Score | 2 Months | -2.481 Score on a Scale | Standard Deviation 1.834 |
VA LV VFQ-48--Composite Score
he VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 and \>=-2.22. Scores out of this range indicate something other than visual impairment is governing the patient's responses. The reading domain score is calculated by calculating the average score of reading items. The composite score approximates a person's visual ability. The score is calculated using Massof's algorithm using the inverse hyperbolic tangent equation. For the composite score, a lower score is better.
Time frame: 3 months
Population: Only one subject completed this outcome measure during the 3 month follow-up due to study timeline constraints.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Composite Score | -2.415 Score on a Scale |
VA LV VFQ-48--Composite Score
he VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 and \>=-2.22. Scores out of this range indicate something other than visual impairment is governing the patient's responses. The reading domain score is calculated by calculating the average score of reading items. The composite score approximates a person's visual ability. The score is calculated using Massof's algorithm using the inverse hyperbolic tangent equation. For the composite score, a lower score is better.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Composite Score | -2.095 Score on a Scale |
VA LV VFQ-48--Item Score
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 (most difficult) and \>=-2.22 (least difficult). Scores out of this range indicate something other than visual impairment is governing the patient's responses. The Item Score is the average functional reserve of all the items in the questionnaire excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons). Functional reserve is the difference between a patient's visual ability and the visual ability needed to perform an activity.
Time frame: 3 months
Population: Only one subject completed this outcome measure during the 3 month follow-up due to study timeline constraints.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Item Score | 2.063 Score on a Scale |
VA LV VFQ-48--Item Score
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 (most difficult) and \>=-2.22 (least difficult). Scores out of this range indicate something other than visual impairment is governing the patient's responses. The Item Score is the average functional reserve of all the items in the questionnaire excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons). Functional reserve is the difference between a patient's visual ability and the visual ability needed to perform an activity.
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Item Score | 1.955 Score on a Scale |
VA LV VFQ-48--Reading Domain Score
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The reading domain score is calculated by calculating the average score of reading items. Scores range from 0 to 3.5 logits, with higher scores denoting better ability to perform activities. The Reading Domain Score is the average functional reserve of the items measuring the reading functional domain, excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
Time frame: 3 months
Population: Only one subject completed this outcome measure during the 3 month follow-up due to study timeline constraints.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Reading Domain Score | 2.673 Score on a Scale |
VA LV VFQ-48--Reading Domain Score
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The reading domain score is calculated by calculating the average score of reading items. Scores range from 0 to 3.5 logits, with higher scores denoting better ability to perform activities. The Reading Domain Score is the average functional reserve of the items measuring the reading functional domain, excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
Time frame: Baseline, 2 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Reading Domain Score | Baseline | 1.839 Score on a Scale | Standard Deviation 1.05 |
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Reading Domain Score | 2 Months | 2.230 Score on a Scale | Standard Deviation 0.982 |
VA LV VFQ-48--Reading Domain Score
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The reading domain score is calculated by calculating the average score of reading items. Scores range from 0 to 3.5 logits, with higher scores denoting better ability to perform activities. The Reading Domain Score is the average functional reserve of the items measuring the reading functional domain, excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons).
Time frame: 6 months
Population: The study's start was delayed due to COVID so only 1 participant was able to complete the 6 month follow-up within the grant time frame.
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | VA LV VFQ-48--Reading Domain Score | 2.549 Score on a Scale |
Veterans Affairs Low Vision Visual Function Questionnaire-48 (VA LV VFQ-48)--Item Score
The VA LV VFQ-48 is a self-report instrument designed to measure difficulty visually impaired persons have performing daily activities. The acceptable range for the average item score is \<= 2.34 (most difficult) and \>=-2.22 (least difficult). Scores out of this range indicate something other than visual impairment is governing the patient's responses. The Item Score is the average functional reserve of all the items in the questionnaire excluding items which were rated Unscored (Difficult / don't do for Non-Visual Reasons). Functional reserve is the difference between a patient's visual ability and the visual ability needed to perform an activity.
Time frame: Baseline, 2 months
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Virtual Reality (VR) Treatment--Deficit Eye | Veterans Affairs Low Vision Visual Function Questionnaire-48 (VA LV VFQ-48)--Item Score | Baseline | 1.248 Score on a Scale | Standard Deviation 0.898 |
| Virtual Reality (VR) Treatment--Deficit Eye | Veterans Affairs Low Vision Visual Function Questionnaire-48 (VA LV VFQ-48)--Item Score | 2 Months | 1.704 Score on a Scale | Standard Deviation 0.948 |
Color Vision Test
Change in the percentage of correctly identified trials for each color.
Time frame: First visit after the completion of rehabilitation (1 or 2 months)
Grating Acuity Test
Change in the percentage of correctly identified trials.
Time frame: First visit after the completion of rehabilitation (1 or 2 months)
Shape Recognition Test
Change in the percentage of correctly identified trials.
Time frame: First visit after the completion of rehabilitation (1 or 2 months)